Physician

Paul B. Bandelin, DO

According to 2025 Medicare claims, Paul Bandelin, DO (NPI: 1497805071) practices dermatology in the Mankato, MN market, with the plurality of this provider's patient population coming from Nicollet, MN. This provider's primary affiliated billing organization is MANKATO CLINIC LTD (NPI: 1629044029; TIN: 410849339) and primary practice location at 56082-5385. Bandelin is affiliated with the Stratum Med ACO (ACO ID: A4527), participating under the MSSP model.

Bandelin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 594 traditional Medicare patients, billed 3,876 HCPCS/CPT codes, and received $215,074 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 671 prescription claims across 250 beneficiaries totaling $797,462 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 1 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $22,066 to $215,074. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,491 to $797,462. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$118K$236K2016 Medicare payment: $22,066 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $64,970 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $116,716 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $219,262 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $179,870 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $229,452 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $199,896 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $236,348 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $215,074 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201675453$22,066
20171981,247$64,970
20183021,966$116,716
20195003,179$219,262
20204462,829$179,870
20215213,121$229,452
20224803,151$199,896
20236013,977$236,348
20245943,876$215,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$399K$797K2016 Drug cost: $4,491 (USD; Tot_Drug_Cst)2017 Drug cost: $20,465 (USD; Tot_Drug_Cst)2018 Drug cost: $288,985 (USD; Tot_Drug_Cst)2019 Drug cost: $321,801 (USD; Tot_Drug_Cst)2020 Drug cost: $362,380 (USD; Tot_Drug_Cst)2021 Drug cost: $345,038 (USD; Tot_Drug_Cst)2022 Drug cost: $504,465 (USD; Tot_Drug_Cst)2023 Drug cost: $582,423 (USD; Tot_Drug_Cst)2024 Drug cost: $797,462 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20166191$4,491
2017151390$20,465
2018238640$288,985
2019234638$321,801
2020198577$362,380
2021257632$345,038
2022235583$504,465
2023242571$582,423
2024250671$797,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth180207$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more406541$62
17000Destruction of precancer skin growth, 1 growth244316$35
88305Pathology examination of tissue using a microscope, intermediate complexity209426$25
17003Destruction of precancer skin growth, 2-14 growths2011,242$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab25700$205,126
Humira(Cf) PenAdalimumab19532$188,480
Cosentyx Sensoready (2 Pens)Secukinumab25700$182,809
Humira PenAdalimumab16448$110,557
OtezlaApremilast12360$56,558

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$23Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Paul B. Bandelin, DO?

Tedicare shows public-source Medicare data for Paul B. Bandelin, DO (NPI 1497805071), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul B. Bandelin, DO have ACO affiliation data?

Paul B. Bandelin, DO is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527).

What billing organization is linked to Paul B. Bandelin, DO?

Paul B. Bandelin, DO is linked to MANKATO CLINIC LTD (billing NPI 1629044029) in the available physician profile data.

Does Paul B. Bandelin, DO have Open Payments data?

Paul B. Bandelin, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.